Publicaciones en las que colabora con Francisco Javier Gil Bea (12)

2024

  1. A mammalian-specific Alex3/Gαq protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival

    Science Signaling, Vol. 17, Núm. 822

  2. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

2022

  1. Defects of Nutrient Signaling and Autophagy in Neurodegeneration

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. A multicentre validation study of the diagnostic value of plasma neurofilament light

    Nature Communications, Vol. 12, Núm. 1

  2. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge

    British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278

  3. The skeletal muscle emerges as a new disease target in amyotrophic lateral sclerosis

    Journal of Personalized Medicine, Vol. 11, Núm. 7

2020

  1. A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262

  2. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage

    Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299

2019

  1. Amyotrophic lateral sclerosis: A complex syndrome that needs an integrated research approach

    Neural Regeneration Research, Vol. 14, Núm. 2, pp. 193-196

2018

  1. Clinical evidences supporting the Src/c-Abl pathway as potential therapeutic target in amyotrophic lateral sclerosis

    Journal of the Neurological Sciences

  2. Retinoids and amyotrophic lateral sclerosis

    JAMA Neurology

2016

  1. ALS: A bucket of genes, environment, metabolism and unknown ingredients

    Progress in Neurobiology, Vol. 142, pp. 104-129